These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6818116)

  • 1. [Molsidomine in the long-term treatment of angina pectoris].
    Blasini R; Brügmann U; Mannes A; Rudolph W
    Herz; 1982 Oct; 7(5):307-16. PubMed ID: 6818116
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synergic action of molsidomine and atenolol in patients with exertion angina. Cycloergometric study].
    Gimeno JV; Olagüe J; Bueno FJ; Tellols R; Martín G; Ferrer J
    Med Clin (Barc); 1984 Nov; 83(15):624-8. PubMed ID: 6549203
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corvaton in the ambulatory treatment of patients with angina pectoris].
    Bichan NA
    Klin Med (Mosk); 1984 Oct; 62(10):39-40. PubMed ID: 6549037
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris].
    Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W
    Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Duration of the antianginal effect of oral molsidomine in exertion angina. Double-blind, crossed and randomized study].
    Bordes P; Gimeno JV; Olagüe J; Ferrer J; Hernández M; Algarra F
    Rev Esp Cardiol; 1986; 39(2):138-42. PubMed ID: 3523649
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rheological properties of blood in patients with stenocardia during treatment with obsidan, corvatone and corinfar].
    Korabel'shchikova NI; Bichko MV; Rishko NV
    Vrach Delo; 1985 Apr; (4):19-21. PubMed ID: 3892905
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
    Rudolph W; Dirschinger J
    Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of using corvaton on patients with unstable stenocardia].
    Vakaliuk IP
    Vrach Delo; 1984 Nov; (11):18-21. PubMed ID: 6442043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
    Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE
    Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and hemodynamic effects of the new dilator drug molsidomine.
    Malcolm AD
    Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molsidomine: evaluation of a single dose using the exercise test].
    Ruano J; Zueco J; Colman T; López C; Pajarón A
    Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
    De Backer GG; Derese A
    Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
    Witchitz S; Kolsky H; Moisson P; Valette H
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
    Strasser R; Klepzig H; Ostrowski J; Resag K
    MMW Munch Med Wochenschr; 1983 Feb; 125(8):156-8. PubMed ID: 6405248
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of coronary heart disease with molsidomine].
    Kaliman J; Uhlir H; Klicpera M
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.